SEC CIK 1605860

Theodosopoulos Nikos

Reported ownership across 3 companies, sourced from SEC Form 4 filings and updated daily.

Current Positions

CompanyShares OwnedAs Of
HLITview stock →189,9562022-08-12
ADTNview stock →65,9632025-12-31
ANETview stock →26,0022023-05-22

Position History — HLIT

Reported shares owned immediately after each Form 4 transaction, over time.

064,582129,163193,7452016-022016-112017-022018-022019-022020-022021-022021-112021-112022-022022-08

Recent Filings — HLIT

DateActivitySharesPriceOwned After
2022-08-12Option exercise (derivative)7,054$0.000
2022-08-12Option exercise7,054$0.00189,956
2022-02-17Grant / award (derivative)14,395$0.0014,395
2022-02-15Option exercise (derivative)19,157$0.000
2022-02-15Option exercise19,157$0.00182,902
2021-11-03Option exercise (derivative)30,000$7.580
2021-11-03Open-market sale30,000$10.60163,745
2021-11-03Option exercise30,000$7.58193,745
2021-02-17Grant / award (derivative)19,157$0.0019,157
2021-02-15Option exercise (derivative)23,184$0.000
2021-02-15Option exercise23,184$0.00163,745
2020-03-18Grant / award (derivative)23,184$0.0023,184
2020-02-15Option exercise (derivative)21,238$0.000
2020-02-15Option exercise21,238$0.00140,561
2019-04-03Grant / award (derivative)21,238$0.0021,238
2019-02-15Option exercise (derivative)33,802$0.000
2019-02-15Option exercise33,802$0.00119,323
2018-03-09Grant / award (derivative)33,802$0.0033,802
2018-02-15Option exercise (derivative)20,690$0.000
2018-02-15Option exercise20,690$0.0085,521
2017-03-27Grant / award (derivative)20,690$0.0020,690
2017-02-15Option exercise (derivative)24,000$0.000
2017-02-15Option exercise24,000$0.0064,831
2016-11-15Open-market buy25,000$4.7540,831
2016-03-14Grant / award (derivative)24,000$0.0024,000
2016-02-15Option exercise (derivative)15,831$0.000
2016-02-15Option exercise15,831$0.0015,831
2015-03-13Grant / award (derivative)30,000$7.5830,000
2015-03-13Grant / award (derivative)15,831$0.0015,831

Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.